$6.71 0.08 (+1.21%)
11/20/2009 4:00 PM

Exelixis, Inc. (EXEL)

CAPS Rating: 4 out of 5

A development-stage biotechnology company dedicated to the discovery and development of novel small molecule therapeutics for the treatment of cancer and other serious diseases.

Current Price $6.71 Mkt Cap $720.56M
Open $6.56 P/E Ratio 0.00
Prev. Close $6.63 Div. (Yield) N/A (N/A)
Daily Range $6.45 - $6.72 Volume 1,137,820
52-Wk Range $2.11 - $8.00 Avg. Daily Vol. 1,045,000

EXEL News and Commentary

Caps

How do you think EXEL will perform vs the S&P 500?

Add Stock to Watchlist

All Members

2,264 Outperform
86 Underperform
 

All-Star Members

600 Outperform
26 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top EXEL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

jbonds (89.99)
Submitted May 28, 2009

Exelixis and Sanofi-Aventis sign global license agreement for XL147 & XL765 and launch collaboration for discovery of PI3K inhibitors Sanofi-Aventis (SNY) and co announce a global license agreement for XL147 and XL765 and a collaboration for the… More

0 Comments | Reply | Report this Post

BRADYstocks (67.39)
Submitted February 26, 2008

This sector is a scary one! Fear, though, is a fools game. I don't expect this stock to move upwards in the very near future. The cash burn is, well, similar to that Texas A&M bonfire tradition.

0 Comments | Reply | Report this Post
EXEL VS S&P 500 (SPY)

Recent Community Commentary

Read the most recent pitches from members about EXEL.

Recs

0
Member Avatar cg690679 (< 20) Submitted: 11/19/2009 7:03:33 PM : Outperform Start Price: $6.56 EXEL Score: +2.12

long list of probables..

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar SierraBlue (< 20) Submitted: 11/17/2009 10:03:04 PM : Outperform Start Price: $7.10 EXEL Score: -3.85

Telechart Pick

Report this Post 0 Comments | Reply | Permalink

Recs

0
Member Avatar justinr (59.68) Submitted: 11/16/2009 11:10:51 AM : Outperform Start Price: $7.20 EXEL Score: -5.18

Outperform

Report this Post 0 Comments | Reply | Permalink
View All 377 Pitches »

Leaderboard

Find the members with the highest scoring picks in EXEL.

Score Leader

Nordaak

Nordaak (97.85) Score: +139.19

The Score Leader is the member with the highest score across all their picks in EXEL.

Top
Pick 		Member Name Member
Rating 		Start
Date 		Call Time
Frame 		Start
Price 		Stock
Gain 		S&P
Gain 		Score Commentary
Nordaak 97.85 11/21/2008 Outperform NS $2.34 +186.75% +47.57% +139.19
Renegadecj 71.88 11/24/2008 Outperform 5Y $2.50 +168.40% +34.73% +133.67
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. BringUs 78.19 11/26/2008 Outperform NS $2.56 +162.11% +33.10% +129.01
TRock1081 97.26 11/24/2008 Outperform 5Y $2.57 +161.09% +34.08% +127.01
botso < 20 11/21/2008 Outperform 5Y $2.48 +170.56% +47.58% +122.98
massexile < 20 11/24/2008 Outperform 1Y $2.71 +147.60% +36.70% +110.91
trsteff < 20 11/25/2008 Outperform 5Y $2.91 +130.58% +28.50% +102.08
nvmk < 20 11/25/2008 Outperform 1Y $2.91 +130.58% +28.50% +102.08
MattH42004 99.91 10/29/2008 Outperform 5Y $3.02 +122.19% +20.29% +101.90 1 Comment
SlotRacer 69.65 10/30/2008 Outperform 1Y $3.11 +115.76% +16.87% +98.89 2 Comments
View Complete Scorecard »

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Member Name Member
Rating		 Start
Date		 Call Time
Frame		 Start
Price		 Stock
Gain		 S&P
Gain		 Score End Date Commentary
TrackIcahn 22.83 2/24/2009 Outperform 1Y $4.69 +43.07% +47.92% -4.85 1 Comment
TrackMerriman < 20 10/16/2008 Outperform NS $4.15 +71.08% +21.49% +49.60 11/18/2009 @ $7.10
TrackCanaccord 78.23 7/8/2008 Outperform NS $5.19 +12.91% +1.82% +11.08 8/6/2008 @ $5.86
TrackSoros 24.12 3/31/2008 Outperform NS $6.95 -3.45% -14.01% +10.56 1 Comment
TrackEveillard 88.00 12/31/2007 Outperform NS $8.63 -22.25% -22.00% -0.25 1 Comment
TrackLazardCapit < 20 9/14/2007 Outperform NS $10.44 -35.73% -22.37% -13.36

Featured Broker Partners